Dr. Jeffrey J. Raizer

Dr. Jeffrey J. Raizer, MD, is a nationally respected neuro-oncologist specializing in the diagnosis and treatment of primary brain tumors, metastatic brain tumors, and central nervous system complications of cancer. He serves as Co-Director of the Northwestern Medicine Lou and Jean Malnati Brain Tumor Institute and is a Professor of Neurology at Northwestern University Feinberg School of Medicine. Dr. Raizer earned his medical degree from the State University of New York at Buffalo, completed his residency in neurology at Yale-New Haven Hospital, and pursued fellowship training in neuro-oncology at Memorial Sloan Kettering Cancer Center. He is board-certified in neurology with special expertise in medical neuro-oncology.

Dr. Raizer is recognized for his clinical and research leadership in treating glioblastomas, astrocytomas, and leptomeningeal metastases, as well as managing neurologic complications in cancer patients. His work integrates advanced imaging, novel chemotherapeutic agents, and clinical trial design to improve both survival and quality of life for patients facing complex neurologic cancers. He has served as principal investigator on numerous clinical trials and has published extensively in peer-reviewed journals, contributing to advancements in both targeted therapies and supportive care in neuro-oncology. His research continues to focus on translating scientific discoveries into effective, individualized treatment strategies for patients with central nervous system tumors.

In addition to his clinical and academic roles, Dr. Raizer is a committed educator and mentor to neurology residents, oncology fellows, and junior faculty. He is an active member of the Society for Neuro-Oncology and the American Academy of Neurology, where he contributes to shaping clinical guidelines and advancing education in his field. Through his dedication to patient care, research innovation, and academic mentorship, Dr. Raizer stands as a leading figure in the evolving landscape of neuro-oncology.